EcoDrugPlus

Integrin Subunit Beta 6

Ensembl ID : ENSDNOG00000019548
Gene Symbol: ITGB6
4 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSDNOG00000012912
Gene Symbol: ITGB7
2 Cross references
159 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSDNOG00000009711
Gene Symbol: ITGB8
4 Cross references
207 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSDNOG00000039429
Gene Symbol: ICAM1
4 Cross references
94 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSDNOG00000005890
Gene Symbol: IRAK4
2 Cross references
202 Possible Orthologues:

Interleukin-6-Like

Ensembl ID : ENSDNOG00000023693
Gene Symbol: LOC101429481
3 Cross references
161 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSDNOG00000004692
Gene Symbol: IDH2
4 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSDNOG00000010757
Gene Symbol: KLKB1
4 Cross references
209 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSDNOG00000031031
Gene Symbol: KEAP1
2 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSDNOG00000015773
Gene Symbol: KDR
2 Cross references
199 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSDNOG00000017304
Gene Symbol: KIF11
2 Cross references
203 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSDNOG00000016079
Gene Symbol: KIF5B
2 Cross references
288 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).